Nathan Caffo - 26 Jul 2021 Form 3 Insider Report for Candel Therapeutics, Inc. (CADL)

Role
Chief Business Officer
Signature
/s/ Nathan Caffo
Issuer symbol
CADL
Transactions as of
26 Jul 2021
Net transactions value
$0
Form type
3
Filing time
26 Jul 2021, 21:18:46 UTC
Next filing
02 Aug 2021
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"Nathan Caffo filed Form 3 for Candel Therapeutics, Inc. (CADL) on 26 Jul 2021."

Quick Takeaways

  • This page summarizes Nathan Caffo's Form 3 filing for Candel Therapeutics, Inc. (CADL).
  • 0 reported transactions and 1 derivative row are listed below.
  • Filing timestamp: 26 Jul 2021, 21:18.

What Changed

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: $0.

Why This Matters

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Official SEC Source

Official SEC Source

Ownership activity is grounded in SEC Form 3 disclosures.

See Original Filing

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CADL Stock Option (Right to Buy) 26 Jul 2021 Common Stock 296,144 $1.55 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of this option shall vest and become exercisable on September 24, 2021, with the remainder vesting in 36 substantially equal monthly installment thereafter.

Sponsored